Xhepa, Erion; Tada, Tomohisa; Kufner, Sebastian; Ndrepepa, Gjin; Byrne, Robert A; Kreutzer, Johanna; Ibrahim, Tareq; Tiroch, Klaus; Valgimigli, Marco; Tölg, Ralf; Cassese, Salvatore; Fusaro, Massimiliano; Schunkert, Heribert; Laugwitz, Karl L; Mehilli, Julinda; Kastrati, Adnan (2017). Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials. Catheterization and cardiovascular interventions, 89(1), pp. 1-10. Wiley-Blackwell 10.1002/ccd.26645
Text
Xhepa_et_al-2016-Catheterization_and_Cardiovascular_Interventions.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (221kB) |
OBJECTIVES
To evaluate the long-term prognostic value of risk scores in the setting of drug-eluting stent (DES) implantation for uLMCA.
BACKGROUND
Data on the prognostic value of novel risk scores developed to select the most appropriate revascularization strategy in patients undergoing DES implantation for uLMCA disease are relatively limited.
METHODS
The study represents a patient-level pooled analysis of the ISAR-LEFT-MAIN (607 patients randomized to paclitaxel-eluting or sirolimus-eluting stents) and the ISAR-LEFT-MAIN-2 (650 patients randomized to everolimus-eluting or zotarolimus-eluting stents) randomized trials. The Syntax Score (SxScore) as well the Syntax Score II (SS-II), the EuroSCORE and the Global Risk Classification (GRC) were calculated. The primary outcome was all-cause mortality.
RESULTS
At a mean follow-up of 3 years there were 160 deaths (12.7%). The death-incidence was significantly higher in the upper tertiles than in the intermediate or lower ones for all risk scores (log-rank test P < 0.01 for all comparisons). The discriminatory power of a multivariable model for prediction of 3-year mortality was significantly improved after the inclusion of EuroSCORE (adjusted area under the receiver operating characteristic (ROC) curve = 0.779, 95% confidence interval 0.747 to 0.810, P = 0.008), but not after the inclusion of SxScore, SS II, or GRC.
CONCLUSIONS
In patients undergoing DES implantation for uLMCA disease, all evaluated risk scores were able to stratify the mortality risk at long-term follow-up. EuroSCORE was the only risk score that significantly improved the discriminatory power of a multivariable model to predict long-term mortality. © 2016 Wiley Periodicals, Inc.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Valgimigli, Marco |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1522-1946 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Daria Vogelsang |
Date Deposited: |
12 Apr 2017 09:04 |
Last Modified: |
05 Dec 2022 15:01 |
Publisher DOI: |
10.1002/ccd.26645 |
PubMed ID: |
27515100 |
Uncontrolled Keywords: |
clinical trials; drug-eluting stent; left main coronary disease; percutaneous coronary intervention; risk stratification |
BORIS DOI: |
10.7892/boris.92846 |
URI: |
https://boris.unibe.ch/id/eprint/92846 |